
Sign up to save your podcasts
Or


In this video Dr. Fahy discusses the TRIIM-X trial, which is the follow on to the original TRIIM trial. We discuss the differences from TRIIM and the current state of the trial. It is still open for enrolment!
Dr. Greg Fahy is a world renowned cryobiologist and is also the chief science officer, and co-founder, of Intervene Immune, a company which pioneers treatments for thymus regeneration and age-related immune system decline. Dr. Fahy Designed and led the pilot TRIIM trial which first time showing both thymus rejuvenation and reversal of human epigenetic age. He is now running the follow up phase II trial TRIIM-X with the aim of confirming and extending the results.
If you would like to support our channel, we’d love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan
You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan
By Modern Healthspan3.6
77 ratings
In this video Dr. Fahy discusses the TRIIM-X trial, which is the follow on to the original TRIIM trial. We discuss the differences from TRIIM and the current state of the trial. It is still open for enrolment!
Dr. Greg Fahy is a world renowned cryobiologist and is also the chief science officer, and co-founder, of Intervene Immune, a company which pioneers treatments for thymus regeneration and age-related immune system decline. Dr. Fahy Designed and led the pilot TRIIM trial which first time showing both thymus rejuvenation and reversal of human epigenetic age. He is now running the follow up phase II trial TRIIM-X with the aim of confirming and extending the results.
If you would like to support our channel, we’d love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan
You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

779 Listeners

7,205 Listeners

5,001 Listeners

1,534 Listeners

8,485 Listeners

1,724 Listeners

2,628 Listeners

9,254 Listeners

8,594 Listeners

46 Listeners

10,019 Listeners

290 Listeners

29,256 Listeners

2,089 Listeners

1,190 Listeners